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Proteomic characterisation of the placenta has largely been focused on effect of disease, anatomical
features or speciﬁc cell types. We describe an unbiased proteomic mapping analysis to investigate how
the placental proteome changes throughout the organ. A transverse slice of a human placenta was
sectioned into 1  1cm samples. Sections were analysed using label free proteomics. Analysis revealed
two distinct sub-proteomes that did not have anatomical signiﬁcance. One had a muscular proteome and
the other had distinct immunomodulation functions. Chorionic plate enriched proteins highlighted the
fetal tissues high energy requirements whilst mechanisms of the decidua observed included modulation
of cortisone levels.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
There is growing interest regarding mechanisms by which
placental function/dysfunction can affect short and long-term
outcomes in fetal and postnatal life [1]. Variation in gene expres-
sion [2] and the transcriptome [3] of the human placenta have been
described revealing its diverse molecular variation. However, to
date little has been published in relation to detailed documentation
of regional variation or anatomical mapping of the placental pro-
teome. The human proteome atlas is able to describe the placental
proteome through transcriptomic analysis and immunohisto-
chemistry in regards to known placental cell types [4] but not in
relation to regional or anatomical variation. Placental proteome
studies have largely been conducted in respect to identifying
changes in disease such as preeclampsia and fetal growth restric-
tion [5,6]. Many studies have used limited samples from poorly
deﬁned sites within the placenta, such as a ‘cotyledon’. However,
the tissue proteome of an organ can differ markedly according to
sub-anatomical regions and functional variation, which can mark-
edly affect methodologies for how proteomic studies should be
performed. This study has investigated whether there is variation
across the placenta andwhether sub-proteomes of the human term
placenta represent functional differences in relation to sites of there).
Ltd. This is an open access article uplacenta proteome map.2. Methods
2.1. Detailed methods are provided in supplementary information
A placenta from a clinically uncomplicated, term normal vaginal
delivery was used for this study, donated for research with
appropriate consent and ethical approval as part of a larger study
examining placental sampling. The placenta was sectioned as
shown in Fig. 1B within 24 h of delivery having been initially
refrigerated at 4. Placental protein was run on a 1D PAGE [7,8]and
analysed using label free proteomics as described previously [9].3. Results & discussion
Total analysis identiﬁed 1096 quantiﬁable proteins of >95%
conﬁdence. The extreme end sections which form the peripheral
margin of the placenta were removed from the analysis; as the
proteomic integrity of these end sections was poor indicating this
area undergoes signiﬁcant degradation post-delivery. To identify if
there was anatomical clustering of proﬁles the data were examined
using principle components analysis, which shows an overall view
of the variation of the placental proteome (Fig. 1A). The PCA
resulted in a four component model (R2X(cum) ¼ 0.581 and
Q2(cum) ¼ 0.126). The ﬁrst and second component best describednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A Placenta proteome PCA score plot. The score plot for the four component PCA model (R2X(cum) ¼ 0.581 and Q2(cum) ¼ 0.126. The ﬁrst and second component best
described the presence of 2 clusters (colour highlighted) of which ﬁrst component explains 17% of the variation and component 2 explains 8.5% of the variation. B illustrates the
sectioning and depicted subproteome clusters identiﬁed in A annotated to the anatomical structure of the placenta.
W.E. Heywood et al. / Placenta 59 (2017) 69e7270the separation of two major sub-proteomes of the human placenta.
Gene Ontology analysis of clustered regions demonstrates that
cluster 1 is enriched with proteins involved in suppression of the
innate immune response, in particular antigen presentation.
Pathway analysis (Supplementary data 4) also identiﬁes antigen
presentation as a signiﬁcant pathway. Cluster 2 appears to have
enriched proteins involved in exocytosis, muscle hypertrophy and
the signalling cascade of SMAD protein import to the nucleus and
protein localisation. Pathway analysis also conﬁrms platelet
degranulation (or exocytosis) and keratinisation as enriched. The
list for cluster 2 also seems to show more extracellular matrix
proteins. These analyses suggest presence of sub-proteomes with
differing functions.3.1. Proteins that do not change throughout the placenta
Proteins that show the least variation across the placenta as
indicated by a coefﬁcient of variation (CV) of <30 across all sections
were proteins involved in integrity of the cytoskeleton and meta-
bolism (supplementary data 2). As expected many other proteins
with lower CV values are known housekeeping proteins. These
proteins which have uniform expression throughout the placenta
could potentially be used for standardising future analyses.3.2. Comparison by anatomical region; maternal vs fetal
The overall placenta PCA analysis does not show marked clus-
tering according to whether sections are from the maternal and
fetal sides of the placenta, indicating that these proteomic differ-
ences are small, presumably since the majority of tissue represents
parenchymal villi from all sites. To identify which proteins are
altered between the maternal and fetal sides rows A and D were
compared. Eleven proteins were altered in both clusters for which
sevenwere enriched towards thematernal side and four at the fetal
side (supplementary data 5). A selection of interesting differently
expressed proteins are shown in a placenta 3D heat map in Fig. 2.
These include; Corticosteroid 11-beta-dehydrogenase isozyme 2
which acts to inactivate cortisone which is an essential process in
pregnancy. This enzyme is inhibited by liquorice (Glycyrrhiza ura-
lensis) and may explain why ingestion of liquorice is not advised
during pregnancy [10,11]. Elevated Tryptophan–tRNA ligase, cyto-
plasmic, may be related to involvement in angiogenesis and sheer
stress response of the endothelium. Fetal side enriched proteins
included the ECM component prolargin, creatine kinase B-type,
required for tissues with high energy demands. cAMP-dependant
protein kinase type II is involved in signal transduction in partic-
ular response to lipid and glucose metabolism and Apolipoprotein
AI is a lipid transport protein. Interestingly, a recent proteomic
Fig. 2. 3D heat map images of placental region speciﬁc enriched proteins. A depicts the 2D image of the sectioned placenta that the 3D images are based on. B shows the tissue
distribution of Corticteroid 11-beta-dehydrogenase isozyme 2 which has signiﬁcant enriched expression in the decidua region and little to no expression in the chorion region. C
shoes images for 2 proteins signiﬁcantly enriched in the chorion and D shows proteins that are enriched according to the unbiased analysis identifying 2 sub-proteomes depictd as
cluster 1 and 2 in Fig. 1.
W.E. Heywood et al. / Placenta 59 (2017) 69e72 71study of preeclampsia reported that Apolipoprotein AI was elevated
in maternal plasma of affected pregnancies [5] indicating this li-
poprotein may play a key functional role during pregnancy. These
enriched proteins suggest that energy metabolism is an important
aspect at this site.
Signiﬁcant fetal enriched proteins show enriched processes for
actin arrangement and muscle ﬁlament sliding and contraction,
keratinisation, embryo implantation and negative regulation of
peptidase activity. The maternal aspect overall has a greater num-
ber of enriched proteins involved in processes such as antigen
presentation, protein folding and modiﬁcation energy metabolism.
This report demonstrates proof of principle that the placenta pro-
teomemay be signiﬁcantly affected by exact sampling site and that
this may be of importance for future studies.Acknowledgements
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